The Latest: Drug maker begins applying for vaccine approval
|
December 1, 2020 3:03 PM
NEW BRUNSWICK, N.J. — Johnson & Johnson, one of the largest drugmakers developing a vaccine against COVID-19, on Tuesday began the process of applying for emergency approval of its vaccine from the European Medicines Agency and Health Canada.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
